Top Banner
When do you give prophylactic treatment in MVP?
19

When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Dec 17, 2015

Download

Documents

Annice Lawrence
Welcome message from author
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
Page 1: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

When do you give prophylactic treatment in MVP?

Page 2: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Clinical approach to determination of the need for prophylaxis in patients with

suspected MVP

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 3: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

• A reasonable approach for endocarditis prophylaxis should consider the following: – the degree to which the patient’s underlying

condition creates a risk of endocarditis – the apparent risk of bacteremia with the procedure – the potential adverse reactions of the prophylactic

antimicrobial agent to be used; and the cost-benefit aspects of the recommended prophylactic regimen

Failure to consider all of these factors may lead to overuse of antimicrobial agents, excessive cost, and risk of adverse drug reactions

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 4: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

• Prophylaxis is recommended in individuals who have a higher risk for developing endocarditis than the general population and is particularly important for individuals in whom endocardial infection is associated with high morbidity and mortality

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 5: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 6: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Endocarditis prophylaxis recommended

High-risk category • Prosthetic cardiac valves • Previous bacterial endocarditis • Complex cyanotic congenital heart disease

Eg. Single ventricle states, Transposition of the great arteries, Tetralogy of Fallot

• Surgically constructed systemic pulmonary shunts or conduits

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 7: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Moderate-risk category • Acquired valvular dysfunction (eg, rheumatic

heart disease) • Hypertrophic cardiomyopathy • Mitral valve prolapse with valvular regurgitation

and/or thickened leaflets

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 8: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Endocarditis prophylaxis NOT recommended

Negligible-risk category • Isolated secundum atrial septal defect • Surgical repair of ASD, VSD or PDA• Previous coronary artery bypass graft surgery • Mitral valve prolapse without valvular regurgitation • Physiologic, functional, or innocent heart murmurs • Previous Kawasaki disease without valvular

dysfunction • Previous rheumatic fever without valvular

dysfunction • Cardiac pacemakers and implanted defibrillators

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 9: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

• Prophylaxis at the time of cardiac surgery should be directed primarily against staphylococci and should be of short duration

• First-generation cephalosporins are most often used• Prophylaxis is most effective when given perioperatively in

doses that are sufficient to assure adequate antibiotic concentrations during and after the procedure

• Antibiotics should be used only during the perioperative period - initiated shortly before a procedure and should not be continued no more than 6 to 8 hours

• In the case of delayed healing, or of a procedure that involves infected tissue, it may be necessary to provide additional doses of antibiotics

Prophylaxis

Page 10: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Prophylaxis

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Antimicrobial prophylaxis administered within 2 hours following the procedure will provide effective prophylaxis

Page 11: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Streptococcus viridans is the most common cause of endocarditis following: – dental or oral procedures– certain upper respiratory tract procedures– bronchoscopy with a rigid bronchoscope– surgical procedures that involve the respiratory

mucosa– esophageal procedures

Page 12: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 13: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

• The recommended standard prophylactic regimen for all these procedures is a single dose of oral amoxicillin to be administered 1 hour before the anticipated procedure – Adult dose is 2.0 g– Pediatric dose is 50 mg/kg (not to exceed adult dose)

• For individuals who are unable to take or unable to absorb oral medications, parenteral Ampicillin sodium is recommended

Durack DT. Prevention of infective endocarditis. N Engl J Med. 1995

Page 14: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

• Individuals who are allergic to penicillin– Clindamycin hydrochloride– Azithromycin or clarithromycin

• When parenteral administration is needed in an individual who is allergic to penicillin, clindamycin phosphate is recommended

Durack DT. Prevention of infective endocarditis. N Engl J Med. 1995

Page 15: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Prophylaxis

• Enterococcus faecalis is the most common cause of bacterial endocarditis that occurs following genitourinary and gastrointestinal tract surgery or instrumentation

• Antibiotic prophylaxis should be directed primarily against Enterococci

Page 16: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 17: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 18: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation

Page 19: When do you give prophylactic treatment in MVP?. Clinical approach to determination of the need for prophylaxis in patients with suspected MVP Prevention.

• High-risk patients– Ampicillin plus gentamicin

• High-risk patients allergic to ampicillin/amoxicillin– Vancomycin plus gentamicin

• Moderate-risk patients– Amoxicillin or ampicillin

• Moderate-risk patients allergic to ampicillin/amoxicillin– Vancomycin

Prevention of Bacterial Endocarditis: Recommendations by the American HeartAssociation